Change of biochemical parameters of sputum in patients with different types of COPD exaserbation

O. Myronenko, O. Plekhanova, O. Lykholat (Dniepropetrovsk, Dnipropetrovsk, Ukraine)

Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session: Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session type: Thematic Poster Session
Number: 2345
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Myronenko, O. Plekhanova, O. Lykholat (Dniepropetrovsk, Dnipropetrovsk, Ukraine). Change of biochemical parameters of sputum in patients with different types of COPD exaserbation. Eur Respir J 2009; 34: Suppl. 53, 2345

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of sputum characteristics with clinical, laboratorial and functional variables in patients with stable COPD
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013



Biochemical parameters of sputum and their correlation with inflammation blood markers in AECOPD patients
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap
Source: Eur Respir J 2014; 43: 421-429
Year: 2013



Comparing sputum rheology and spirometry as pathological markers in respiratory diseases
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Using different pulmonary function parameters for establising reversibility in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 808s
Year: 2006

Relationship of different types of exercise tests to pulmonary function and quality of life in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 68s
Year: 2002

Physiological responses during different clinical exercise protocols in COPD patients
Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment
Year: 2009

Changes in the cellular composition of induced sputum in patients with asthma-COPD overlap
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019


Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters
Source: Eur Respir J 2005; 26: Suppl. 49, 297s
Year: 2005

Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Some local markers indices of saliva inflammation in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 62s
Year: 2004

Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005

Comparison of different activity measures in patients with severe COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 68s
Year: 2006

Comparative assessment of hemodynamic parameters in patients with COPD and CHD treated with different groups of bronchodilators.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018

Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Correlations between SGRQ and other clinical and functional parameters in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 809s
Year: 2006